Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (DAPTACEL) | SANOFI PASTEUR | UNK | — | — |
| DTAPIPVHIB | DTAP + IPV + HIB (PENTACEL) | SANOFI PASTEUR | UNK | — | — |
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | — | — |
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | UNK | — | — |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | UNK | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
it was supposed to be PENTACEL to be administered, the assistant who administered the vaccines got confused whether to inject VAXELIS or PENTACEL; Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and 16-JAN-2025; Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and Pentacel; This non-serious spontaneous safety report was received by partner on 14-JAN-2025 and forwarded to UBC on 16-JAN-2025 from a healthcare professional. Due to the nature of the event, the causality assessment between Vaxelis and the events were not applicable. Further information is expected. Non-significant follow-up information was received by the partner on 27-JAN-2025 and forwarded to UBC on 29-JAN-2025, from other health professional. The case is maintained as non-serious. Due to the nature of the event, the causality between the event "it was supposed to be PENTACEL to be administered, the assistant who administered the vaccines got confused whether to inject VAXELIS or PENTACEL", "Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and 16-JAN-2025", "Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and Pentacel" and Vaxelis was not applicable. Further information is not expected. Significant follow-up information was received by the partner on 27-JAN-2025 and forwarded to UBC on 28-JAN-2025, from other health professional. The case is maintained as non-serious. Due to the nature of the event, the causality between the event "it was supposed to be PENTACEL to be administered, the assistant who administered the vaccines got confused whether to inject VAXELIS or PENTACEL", "Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and 16-JAN-2025", "Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and Pentacel" and Vaxelis was not applicable. Further information is not expected. Significant follow-up information was received by the partner on 30-JAN-2025 and forwarded to UBC on 30-JAN-2025, from other health professional. The case is maintained as non-serious. Due to the nature of the event, the causality between the event "it was supposed to be PENTACEL to be administered, the assistant who administered the vaccines got confused whether to inject VAXELIS or PENTACEL", "Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and 16-JAN-2025", "Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and Pentacel" and Vaxelis was not applicable. Further information is not expected.
Prophylaxis